(VIANEWS) – Shares of Horizon Therapeutics (NASDAQ: HZNP) rose 6.26% to $96.88 at 10:03 EST on Tuesday, following the last session’s downward trend. NASDAQ is jumping 0.41% to $13,751.40, after three successive sessions in a row of gains. This seems, up until now, a somewhat bullish trend exchanging session today.
Horizon Therapeutics’s last close was $91.17, 24.37% below its 52-week high of $120.54.
Today’s last reported volume for Horizon Therapeutics is 355466 which is 77.94% below its average volume of 1611943.
Horizon Therapeutics’s Sales
Horizon Therapeutics’s sales growth is 85.7% for the current quarter and 27.5% for the next. The company’s growth estimates for the current quarter is a negative 11.5% and positive 10.2% for the next.
Horizon Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 79.9%, now sitting on 2.56B for the twelve trailing months.
Horizon Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.44%, a negative 0.19%, and a positive 1.66%, respectively.
Horizon Therapeutics’s highest amplitude of average volatility was 1.83% (last week), 1.38% (last month), and 1.66% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Horizon Therapeutics’s stock is considered to be overbought (>=80).
Horizon Therapeutics’s Stock Yearly Top and Bottom Value
Horizon Therapeutics’s stock is valued at $96.88 at 10:03 EST, way below its 52-week high of $120.54 and way higher than its 52-week low of $66.41.
Horizon Therapeutics’s Moving Average
Horizon Therapeutics’s worth is way below its 50-day moving average of $109.80 and below its 200-day moving average of $100.05.
More news about Horizon Therapeutics (HZNP).